Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Hematology

Gianni Bonadonna Memorial Lecture: “Genetic Signatures and Targetable Pathways in Lymphoid Malignancies”

Hematological Oncology

English

Pod24 and Cr30 Are Promising Surrogate Endpoints for Assessing the Outcome of Patients With Advanced Stage Follicular Lymphoma Enrolled in the Foll05 Trial by Fil.

Hematological Oncology

English

Preliminary Results of a Phase 1 Dose Escalation Study of the First-In-Class Anti-Cd74 Antibody Drug Conjugate (Adc), Stro-001, in Advanced B-Cell Malignancies

Hematological Oncology

English

A PHASE 2 CLINICAL TRIAL OF RITUXIMAB AND Β-Glucan PGG IN RELAPSED/REFRACTORY INDOLENT B-Cell NON-HODGKIN LYMPHOMA

Hematological Oncology

English

Autologous Stem Cell Transplantation in First Remission Significantly Prolongs Progression-Free and Overall Survival in Mantle Cell Lymphoma

Hematological Oncology

English

Low Levels of Immuno-Suppressor Cells Promote Responses to a Haploidentical Natural Killer Cell Therapy and Induce Remissions in Non-Hodgkin Lymphoma

Hematological Oncology

English

Characteristics and Natural History of Primary Vitreoretinal Lymphoma (PVL) Compared to the Primary Lymphoma of the CNS (PCNSL)

Hematological Oncology

English

Clinically Indolent Primary Hhv8-Negative Effusion-Based Lymphoma Is Characterized by Complex Genomic Alterations With Aggressive Features

Hematological Oncology

English

Interim Update From a Phase 2 Multicenter Study of Tazemetostat, an Ezh2 Inhibitor, in Patients With Relapsed or Refractory Follicular Lymphoma

Hematological Oncology

English

Retreatment With Nivolumab in Patients With R/R Classical Hodgkin Lymphoma After Discontinuation of the Therapy With Immune Checkpoint Inhibitors

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Hematology

Gianni Bonadonna Memorial Lecture: “Genetic Signatures and Targetable Pathways in Lymphoid Malignancies”

Pod24 and Cr30 Are Promising Surrogate Endpoints for Assessing the Outcome of Patients With Advanced Stage Follicular Lymphoma Enrolled in the Foll05 Trial by Fil.

Preliminary Results of a Phase 1 Dose Escalation Study of the First-In-Class Anti-Cd74 Antibody Drug Conjugate (Adc), Stro-001, in Advanced B-Cell Malignancies

A PHASE 2 CLINICAL TRIAL OF RITUXIMAB AND Β-Glucan PGG IN RELAPSED/REFRACTORY INDOLENT B-Cell NON-HODGKIN LYMPHOMA

Autologous Stem Cell Transplantation in First Remission Significantly Prolongs Progression-Free and Overall Survival in Mantle Cell Lymphoma

Low Levels of Immuno-Suppressor Cells Promote Responses to a Haploidentical Natural Killer Cell Therapy and Induce Remissions in Non-Hodgkin Lymphoma

Characteristics and Natural History of Primary Vitreoretinal Lymphoma (PVL) Compared to the Primary Lymphoma of the CNS (PCNSL)

Clinically Indolent Primary Hhv8-Negative Effusion-Based Lymphoma Is Characterized by Complex Genomic Alterations With Aggressive Features

Interim Update From a Phase 2 Multicenter Study of Tazemetostat, an Ezh2 Inhibitor, in Patients With Relapsed or Refractory Follicular Lymphoma

Retreatment With Nivolumab in Patients With R/R Classical Hodgkin Lymphoma After Discontinuation of the Therapy With Immune Checkpoint Inhibitors